Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias.

AIM: Histamine H(3) receptor antagonists have been proposed as a novel therapeutic approach for the symptomatic treatment of Alzheimer's disease (AD). However, it is unclear whether there is a neurochemical basis for extending their potential use in vascular and mixed dementias. In this study,...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Sheng, Y, Lee, J, Medhurst, A, Wilcock, G, Esiri, M, Wong, P, Chen, C, Lai, M
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2012